Patient advocacy and the future of systemic therapies in liver cancer: an interview with Ghassan Abou-Alfa

Discussing the importance of patient advocacy and the advancement of systemic therapies for the treatment of liver cancer, we catch up with Hepatic Oncology’s latest editorial board member Ghassan Abou-Alfa.

Detalles Bibliográficos
Autor principal: Abou-Alfa, Ghassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2020
Materias:
Interview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137175/
https://www.ncbi.nlm.nih.gov/pubmed/32273973
http://dx.doi.org/10.2217/hep-2020-0008
Descripción
Sumario:Discussing the importance of patient advocacy and the advancement of systemic therapies for the treatment of liver cancer, we catch up with Hepatic Oncology’s latest editorial board member Ghassan Abou-Alfa.

Ejemplares similares